For further processing only. Others beta-1 4-Galactosyltransferase rec. EQ β-1,4-Galactosyltransferase, rec. EQ 78 1403506419168 The sale of the Product does not exhaust or grant any rights in third party patents including patents of companies of the F. Hoffmann - La Roche AG group of companies, in particular, for the use of modified antibodies obtained by using the product. 3.1.1.2.13.4 human, expressed in CHO-K1 cells 08098182103 beta-1,4-Galactosyltransferase, rec. EQ beta-1,4-Galactosyltransferase, rec. EQ Reagents, kits custom fill Not Available CustomBiotech product. Please contact your local representative. Unit of measure is "gram". EC 2.4.1.38 (β-N-acetylglucosaminylglycopeptide β-1,4-galactosyltransferase) en β-1,4-Galactosyltransferase, rec. EQ can be used for in vitro glycoengineering of glycoproteins, e.g. therapeutic proteins, in drug development and manufacturing. en Benefits from in vitro glycoengineering to modify glycosylation of therapeutic proteins: Time- and cost-saving generation of glycan variants to facilitate drug development. Optimized glycosylation without compromising other CQAs or product yield. Improved lot-to-lot consistency to reduce risk of product quality variation and resulting delays. Generation of glycoprofiles which may not otherwise be generated. Streamlined analytics in comparability studies. en β-1,4-Galactosyltransferase, rec. EQ is a highly active recombinant human glycosyltransferase, expressed in CHO cells.To use in vitro glycoengineering in drug development and manufacturing processes, enzymes should be of enhanced quality (EQ), compared to enzymes used in early R&D or analytical applications: Enzymes should be tested for host-cell impurities and relevant metal impurities and be available at least in gram amounts.β-1,4-Galactosyltransferase, rec. EQ fulfills those criteria and can also be provided in GMP Grade upon request. en Appearance: Clear and colorless to slightly yellowish solution.Specific activity: >12 U/mgProtein (OD 280 nm) A280 = 0.984: 15 ± 1.5 mg/mLPurity (HPLC): >90%Bioburden: ≤100 CFU/mLEndotoxin: ≤10 EU/mgHost cell protein: ≤ 4000 ppmHost cell DNA: ≤ 100 pg/mgHeavy metal: (Cd, Co, V, Ni, Ag, Se); ≤ 10 ppmStability: At –15 to –25°C within specification range for 18 months (08 098 182 103) and 12 months (08 098 182 101). en For in vitro galactosylation of all GlcNAc1-2Man units on glycoproteins and complex molecules such as monoclonal antibodies (MAB), use β-1,4-Galactosyltransferase (B4GalT1) and UDP-Galactose (UDP-Gal). en